Drug intelligence / Profile preview

demegestone

Development stage
Discontinued
Lead developer
Hoechst
Modality
Small Molecules
Administration
Oral
01

Overview

Demegestone is a synthetic steroidal progestin of the 19-norprogesterone class. It acts as a highly potent **agonist** of the **progesterone receptor** and was previously used to treat luteal insufficiency. Demegestone exhibits strong progestogenic activity (about 50 times that of progesterone in animal models) and has little or no androgenic activity; it may have some antiandrogenic effects. The drug also shows low affinity for glucocorticoid and mineralocorticoid receptors and its major metabolite is a moderately potent progestogen with weak mineralocorticoid activity. Demegestone was marketed in France under the brand name Lutionex but has since been discontinued. It was also studied in combination with estrogens as an oral contraceptive and for infertility treatment.

Brand names
Lutionex
Other names
demegestonademegestonum17-methyl-19-norpregna-4,9-diene-3,20-dione
02

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on demegestone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on demegestone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call